Nutritional and endocrine modulation of intracellular calcium: Implications in obesity, insulin resistance and hypertension

Molecular and Cellular Biochemistry

Volumn 188, Issue 1-2, 1998, Pages 129-136

  Zemel, Michael B ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

agouti calcium; Hypertension; Insulin resistance; Obesity

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; FATTY ACID SYNTHASE; INSULIN; TRIACYLGLYCEROL;

ADIPOCYTE; ARTERIAL PRESSURE; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONFERENCE PAPER; HORMONAL REGULATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; MOUSE MUTANT; NUTRITION; OBESITY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM; CALCIUM, DIETARY; ENDOCRINE GLANDS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; INTRACELLULAR FLUID; OBESITY;

AGOUTI; MURINAE;

EID: 0031786583     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006880708475     Document Type: Conference Paper

References (69)

1. Reaven G: Role of insulin resistance in human disease. Diabetes 37: 1595-1607,1988
2. Zemel MB: Insulin resistance, obesity and hypertension: An overview. J Nutrl 25: 1715S-1717S,1995
3. Rocchini AP: Insulin resistance and blood pressure regulation in obese and non-obese subjects. Hypertension 17: 837-842,1991
4. Rowe JW, Young JB, Minaker KL, Stevens AL, Palotta, Landsberg L: Effect of insulin and glucose infusion on sympathetic nervous system activity in normal man. Diabetes 30: 219-225,1981
5. Anderson EA, Hoffman RP, Balor TW, Sinkey CA, Mark AL: Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246-2252,1991
6. Anderson EA, Balor TW, Hoffman RP, Sinkey CA, Mark AL: Increases sympathetic activity but not blood pressure in borderline hypertensive humans. J Clin Invest 89: 621-627,1992
7. Zemel MB, Penler JD, Sowers JR, Simpson L: Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. Am J Physiol 262: H368-H371,1992
8. Zemel MB, Reddy S, Shehin S, Lockette W, Sowers JR: Vascular reactivity in Zucker obese rats: Role of insulin resistance. J Vasc Med Biol 2: 81-85,1990
9. Zemel MB, Reddy S, Sowers JR: Insulin attenuation of vasoconstrictor responses to phenylephrine in Zucker lean and obese rats. Am J Hypertension 4: 537-539,1991
10. 2+-ATPase. Am J Hypertension 5: 637-641,1992
11. Kim YC, Zemel MB: Insulin increases vascular smooth muscle recovery from intracellular calcium loads. Hypertension 22: 74-77,1993
12. Kahn AM, Seidel CL, Allen JC, O'Neil RG: Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 22: 735-742,1993
13. Juncos LA, Ito S, Carretero OA: Disparate effects of insulin on isolated rabbit afferent and efferent arterioles. Hypertension 20: 403,1992
14. Hall JE, Coleman TG, Mizelle HL: Does chronic hyperinsulinemia cause hypertension. Am J Hypertension 2: 171-173,1989
15. Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE: The hemodynamic response to chronic hyperinsulinemia in conscious dogs. Am J Hypertension 4: 164-168,1991
16. Morgan DA, Ray CA, Balon TW, Mark AL: Metformin increases insulin sensitivity and lowers arterial pressure in spontaneously hypertensive rats. Hypertension 20: 421,1992
17. Dubey RK, Zhang HY, Reddy SR, Buegehold MA, Kotchen TA: Pioglitazone attenuates hypertension and growth of renal arteriolar smooth muscle cells in rats. Am J Phsyiol 265: R276-R732,1993
18. Pershadsingh HA, Szollosi J, Bensorn S, Hyun WC, Feurstein BG, Kurtz TW: Effect of ciglitazone on blood pressure and intracellular calcium metabolism. Hypertension 21: 1020-1023,1993
19. Cooper DR, Foote J, Petch C, Schofield PM: Chronic effects of glucose on insulin signaling in A-10 vascular smooth muscle cells. Arch Biochem Biophys 302: 490-498,1993
20. Ban, WJ, Abel MA, Zemel MB: Insulin regulation of vascular smooth muscle glucose transport in insulin-sensitive and resistant rats. Hor Metab Res 28: 271-275,1996
21. 2+ regulation of insulin sensitivity. J Nutr 125: 1738S-1743S,1995
22. Standley PR, Zhang F, Ram JL, Zemel MB, Sowers JR: Insulin attenuates vasopressin-induced calcium transients and voltage-dependent calcium current in rat vascular smooth muscle cells. J Clin Invest 88: 1230-1236,1991
23. Tonyz RM, Tolloczko B, Schiffrin EL: Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells. Hypertension 23 (Suppl. I): 125-128,1994
24. Kahn AM, Seidel CL, Allen JC, O'Neil RG: Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 22: 735-742,1993
25. Levy J, Zemel MB, Sowers JR: Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension. Am J Med 87 (Suppl. 6A): 155-165
26. Zemel MB, Bedford BA, Zemel PC, Marwah O, Sowers JR: Altered cation transport in non-insulin-dependent diabetics: Effects of dietary calcium. J Hypertension 6 (Suppl. 4): S228-S230
27. Shehin SE, Sowers JR, Zemel MB: Impaired vascular smooth muscle 45Ca efflux and hypertension in Zucker obese rats. J Vasc Med Biol 1: 278-282,1989
28. Abel MA, Zemel MB: Impaired recovery of vascular smooth muscle intracellular calcium following agonist stimulation in insulin resistant (Zucker obese) rats. Am J Hypertension 6: 500-504,1993
29. 15Ca flux and blood pressure regulation in streptozotocin-induced diabetic rats. J Vasc Med Biol 2: 47-50,1990
30. 2+-ATPase expression. J Vasc Med Biol 4: 79-84
31. 2+- ATPase gene expression in cultured vascular smooth muscle cells: Role of glucosc-6-phosphate. Biochem J 311: 555-559,1995
32. Draznin B, Sussman K, Kao M, Lewis D, Sherman N: The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem 262: 14385-14388,1987
33. Draznin B: Cytosolic calcium and insulin resistance. Am J Kidney Dis 21 (Suppl. 3): 32-38,1993
34. Segal S, Lloyd S, Sherman N, Sussman KE, Draznin B: Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulindependent diabetes mellitus. Horm Res 34: 39-44,1990
35. Epstein M, Sowers JR: Diabetes mellitus and hypertension. Hypertension 19: 403-418,1992
36. Bursztyn M, Raz I, Mekler J, Ben-Ishay D: Nitrendipine improves glucose tolerance and deoxyglucose uptake in hypertensive rats. Hypertension 23: 1051-1053,1994
37. Beer NA, Jakubowicz DJ, Beer RM, Arocha IR, Nestler JE: Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men. J Clin Endocrinology 76: 178-183,1993
38. Beer NA, Jakubowicz DJ, Beer RM: Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women. J Clin Endocrinology 79: 1077-1081,1994
39. Byyny RL, LoVerde M, Mitchell W, Draznin B: Cytosolic calcium and insulin resistance in elderly patients. Am J Hypertension 5: 459-464,1992
40. Harano Y, Dageyama A,Hirose J, Asakura Y, Yokota T, Ikebuchi M, Suzuki M, Omae T: Improvement of insulin sensitivity for glucose metabolism with the longacting Ca-channel blocker amlodipine in essential hypertensive subjects. Metabolism 44: 315-319,1995
41. Draznin B, Lewis D, Houlder N, Sherman N, Adamo M, Garvey WT, LeRoigh D, Sussman K: Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes. Endocrinology 125: 2341-2349,1989
42. Dohm GL, Elton CW, Friedman JE, Pilch PF, Pories WJ, Atkinson SM Jr, Caro JE: Decreased expression of glucose transporter in muscle from insulin resistant patients. Am J Physiol 260: E459-E463,1991
43. Pederson O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn BB: Evidence altered expression of GLUT1 or GLUTS in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865-870,1990
44. Handberg A, Vaag A, Damsba P, Beck-Nielsen H, Vinten J: Expression of insuilnregulatable glucose transporters in skeletal muscle from type 2 (non-insulindependent) diabetic patients. Diabetologia 33: 625-627,1990
45. Begum N, Leitner W, Reusch J E-B, Sussman KE, Draznin B: Glut-4 phosphorylation and its intrinsic activity. J Biol Chem 268: 3352-3356,1993
46. Begum N, Sussman KE, Draznin B: Calcium-induced inhibition of phosphoserine phosphatase in insuiln target cells is mediated by the phosphorylation and activation of inhibitor 1. J Biol Chem 267: 5959-5963
47. Kida Y, Esposito-Del Puente A, Bogardus C, Molt DM: Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. J Clin Invest 85: 476-481,1990
48. Freidenberg GR, Henry RR, Klein HH, Reichart DR, Olefsky JM: Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjcts. J Clin Invest 79: 240-250,1987
49. Dent P, Lavoinne A, Nakielny S, Caudwell FB: The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348: 302-308,1990
50. 2+ regulates calmodulin binding to IQ motifs in IRS-1. Biochemistry 35: 15883-15889,1996
51. VY- mice: Ectopic expression of the agouti gene. FASEB J 8: 479-488,1994
52. 2+ signaling and lipogenic activity in 3T3-L1 adipocytes. Obesity Res 4: 28s,1996
53. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA: Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 82: 1848-1852,1988
54. Bultman SJ, Michaud EJ, Woychik RP. Molecular characterization of the mouse agouti locus. Cell 71: 1195-1204,1992
55. y) is associated with the disruption of a novel RNA-binding protein. Genes Dev 7: 1203-1213,1993
56. iapy) is correlated with methylation state and is influenced by parental lineage. Genes Dev 8: 1463-1472,1994
57. Klebig ML, Wilkinson JH, Geisler JG, Woychik RP: Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II, and yellow fur. Proc Nat Acad Sci USA 92: 4728-4732,1995
58. Zemel MB, Kim JH, Woychik RP, Michaud EJ, Kadwell SH, Patel IR, Wilkison WO: Agouti regulation of intracellular calcium: Role in the insulin resistance of viable yellow mice. Proc Nat Acad Sci USA 92: 4733-4737,1995
59. Kim JH, Kiefer LL, Woychik RP, Wilkison WO, Truesdale A, Ittoop O, Willard D, Nichols J, Zemel MB: Agouti regulation of intracellular calcium: role of melanocortin receptors. Am J Physiol 272: E379-E384,1997
60. y/a) and non-yellow (a/a) mice in parabiosis. Genetics 48: 1041-1058,1963
61. Johnson PR, Hirsch J: Cellularity of adipose depot in six strains of genetically obese mice. J Lipid Res 13: 2-11,1972
62. Jones BH, Kim JH, Zemel MB, Woychik RP, Michaud EJ, Wilkison WO, Moustaid N: Upregulation of adipocyte metabolism by agouti protein: Possible paracrine actions in yellow mouse obesity. Am J Physiol 270: E192-E196,1996
63. Claycombe KH, Jones BH, Standridge MK, Wilkison WO, Zemel MB, Guo YS, Moustaid N: Transcriptional regulation of the adipocyte fatty acid synthase gene by the agoutti gene product: Interaction with insulin. FASEB J 11: A352,1997
64. Zemel MB, Kim JH, Jones BH, Moore JW, Woychik RP, Moustaid N, Wilkison WO: Agouti gene product regulation of intracellular free calcium results in stimulation of fatty acid synthase. Obesity Res 3: 338s,1995
65. Moore JW, Willard D, Moustaid N, Wilkison WO, Zemel MB: Role of intracellular calcium in agouti and insulin modulation of fatty acid synthase. FASEB J 10: A187,1996
66. Kwon HY, Bultman SJ, Loffler C, Chen WJ, Furdon PJ, Powell JG, Usala AL, Wilkison W, Hansmann I, Woychik RP: Molecular structure and chromosomal mapping of the human homologue of the agouti gene. Proc Nat Acad Sci USA 91: 9760-9764,1994
67. Kim JH, Mynatt RL, Moore JW, Woychik RP, Moustaid N, Wilkison WO and Zemel MB: The effects of calcium channel blockade on agouti-induced obesity. FASEB J 10: 1646-1652
68. 2+ signaling and insulin release. FASEB J 11: A320,1997
69. Mynatt RL, Miltenberger RJ, Klebig ML, Zemel MB, Wilkinson JE, Wilkison WO, Woychik RP: Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity. Proc Nat Acad Sci USA 94: 919-922,1997